Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD)

Acta Gastroenterol Belg. 2018 Jan-Mar;81(1):49-53.

¹ Department of Gastroenterology, Hopital Erasme Brussels, Belgium.
² Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Belgium.
³ Department of Gastroenterology, Centre Hospitalier Universitaire de Liege, Belgium.
⁴ Department of Gastroenterology - Ghent University Hospital - Ghent University, Belgium.
⁵ Department of Gastroenterology, Cliniques Universitaires Saint-Luc UCL Bruxelles, Belgium.
⁶ Department of Gastroenterology, AZ Sint Lucas Brugge, Belgium.
⁷ Department of Gastroenterology, Imeldaziekenhuis, Bonheiden, Belgium.
⁸ Department of Gastroenterology, AZ Delta Roeselare, Belgium.
⁹ Department of Gastroenterology, CHU UCL Mont-Godinne, Belgium.

No abstract available

Keywords: Crohn's disease; anti-TNF; biosimilar; inflammatory bowel disease; ulcerative colitis.

Publication types